American State Bank (Iowa)’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-425
Closed -$57.2K – 136
2023
Q4
$57.2K Hold
425
– – 0.04% 192
2023
Q3
$57.5K Hold
425
– – 0.04% 186
2023
Q2
$60.8K Hold
425
– – 0.04% 187
2023
Q1
$58.9K Hold
425
– – 0.04% 184
2022
Q4
$57.6K Hold
425
– – 0.04% 190
2022
Q3
$46.6K Hold
425
– – 0.04% 195
2022
Q2
$56.1K Hold
425
– – 0.04% 186
2022
Q1
$56.3K Hold
425
– – 0.04% 191
2021
Q4
$49.5K Hold
425
– – 0.03% 201
2021
Q3
$51K Buy
+425
New +$49.5K 0.04% 195

Other funds holding AZN

American State Bank (Iowa)'s AZN Position: Q1 2024 in Review

American State Bank (Iowa) sold out of AstraZeneca (AZN) in Q1 2024, closing a stake of 425 shares — an estimated $57.2K sold.

American State Bank (Iowa) first reported a position in AZN in Q3 2021 and held it in 10 quarters. The position peaked at $60.8K in Q2 2023. 1,142 funds tracked by Wall St. Rank hold AZN as of Q1 2024.

  • American State Bank (Iowa) reported no remaining AstraZeneca position as of Q1 2024 after selling out during the quarter.
  • American State Bank (Iowa) sold 425 AstraZeneca shares in Q1 2024, an estimated $57.2K.
  • American State Bank (Iowa) first reported a position in AstraZeneca in Q3 2021 and held it in 10 quarters.
  • American State Bank (Iowa)'s AstraZeneca position peaked at $60.8K in Q2 2023.
  • 1,142 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2024.

Based on American State Bank (Iowa)'s 13F filing for Q1 2024, filed 14 Apr 2026.